Building A Better Biomarker: PD-L1 Expression Under Spotlight At ASCO

With new data showing correlation to response, use of PD-L1 expression as a biomarker for PD-1/L1 inhibitors was a frequent topic at ASCO. Its limitations point to need for better markers to guide immunotherapy use.